Implementação da Terapia Trombolítica no Hospital São Lucas da PUCRS e no Hospital Mãe de Deus em Porto Alegre, Rio Grande do Sul
DOI:
https://doi.org/10.34024/rnc.2004.v12.8871Palavras-chave:
AVCI, Rt-PAResumo
O Acidente Vascular Cerebral Isquêmico(AVCI) é a maior causa de incapacidades físicas e cognitivas em nosso meio. O uso da terapia trombolítica com rt-PA na fase aguda eleva significativamente a chance de uma recuperação completa. Os hospitais que tratam pacientes com AVC agudo devem ser preparados para o uso desta terapêutica. Neste artigo mostramos a seqüência, o modelo operacional e alguns resultados da implantação do protocolo rt-PA em dois hospitais de referência em Porto Alegre-RS.
Downloads
Referências
Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). In: The Cochrane Library, Issue 1, 2003.
NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
Update on intravenous tissue plasminogen activator for acute stroke: from clinical trials to clinical practice. Can Med Assoc J. 2001;165:311–317.
Hacke W, Kaste, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet. 1998;352:1245–1251.
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC Jr, Lewandowski CA, Kwiatkowski TP, for the NINDS rt-PA Stroke Study Group. Early stroke treatment associated with better outcome. Neurology. 2000;55:1649–1655.
Clark WM, Wissmann S, Albers GW, Jhamandas JH, Madden KP, Hamilton S, for the ATLANTIS Study Investigators. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized con-trolled trial. JAMA. 1999;282:2019 –2026.
Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283: 1151–1158.
Albers GW, Bates VE, Clarke WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study. JAMA. 2000;283:1145–1150.
Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, Mansbach HH, Daley S, Schultz LR, Karanjia PN, Scott P, Dayno JM, Vereczkey-Porter K, Benesch C, Book D, Coplin DM, Dulli D, Levine SR, and the t-PA Stroke Survey Group. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. Neurology. 1999;53:424 –427.
Chapman KM, Woolfenden AR, Graeb D, Johnston DCC, Beckman J, Schulzer M, Teal PA. Intravenous tissue plasminogen activator for acute ischemic stroke: a Canadian hospital’s experience. Stroke. 2000;31:2929–2924.
Zweifler RM, Brody ML, Graves GC, U TT, Drinkard R, Cunningham S, Rothrock JF. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system. Neurology. 1998;50:501–503.
Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology. 2000;54:679–684.
Grotta JC, Burgin WS, El-Mitwalli A, Long M, Campbell M, Morgenstern LB, Malkoff M, Alexandrov AV. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol. 2001;58:2009 –2013.
Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, Schneweis S, Heiss W-D. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke. 1998;29:1544–1549.
Perttu J. Lindsberg, Lauri Soinne, Risto O. Roine, Oili Salonen,Turgut Tatlisumak, Mikko Kallela, MD, Olli Häppölä, Marjaana Tiainen, Elena Haapaniemi, Markku Kuisma, Markku Kaste. Community-Based Thrombolytic Therapy of Acute Ischemic. Stroke in Helsinki. Stroke. 2003;34:1443-1449.
Português
English
Español
